Cite
Evans WE, Pratt CB, Taylor RH, et al. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients. Cancer Chemother Pharmacol. 1979;3(3):161-6doi: 10.1007/BF00262416.
Evans, W. E., Pratt, C. B., Taylor, R. H., Barker, L. F., & Crom, W. R. (1979). Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients. Cancer chemotherapy and pharmacology, 3(3), 161-6. https://doi.org/10.1007/BF00262416
Evans, W E, et al. "Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients." Cancer chemotherapy and pharmacology vol. 3,3 (1979): 161-6. doi: https://doi.org/10.1007/BF00262416
Evans WE, Pratt CB, Taylor RH, Barker LF, Crom WR. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients. Cancer Chemother Pharmacol. 1979;3(3):161-6. doi: 10.1007/BF00262416. PMID: 316744.
Copy
Download .nbib